Broad spectrum influenza virus vaccine
US11576961B2 · kind B2 · utility
24Cited by
51References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2018 |
| Grant date | Feb 14, 2023 |
| Priority date | — |
| Expiry date | Mar 15, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16234
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure relates to broad spectrum influenza virus ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccine. In a preferred embodiment, the vaccine is formulated as a lipid nanoparticle comprising at least one cationic lipid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.